384 related articles for article (PubMed ID: 26514361)
1. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.
Bosnyák E; Kamson DO; Robinette NL; Barger GR; Mittal S; Juhász C
J Neurooncol; 2016 Jan; 126(2):317-25. PubMed ID: 26514361
[TBL] [Abstract][Full Text] [Related]
2. Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.
John F; Bosnyák E; Robinette NL; Amit-Yousif AJ; Barger GR; Shah KD; Michelhaugh SK; Klinger NV; Mittal S; Juhász C
Neuro Oncol; 2019 Feb; 21(2):264-273. PubMed ID: 30346623
[TBL] [Abstract][Full Text] [Related]
3. Multimodal Imaging of Nonenhancing Glioblastoma Regions.
John F; Robinette NL; Amit-Yousif AJ; Bosnyák E; Barger GR; Shah KD; Mittal S; Juhász C
Mol Imaging; 2019; 18():1536012119885222. PubMed ID: 31736437
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates.
Kamson DO; Juhász C; Buth A; Kupsky WJ; Barger GR; Chakraborty PK; Muzik O; Mittal S
J Neurooncol; 2013 Mar; 112(1):121-32. PubMed ID: 23299463
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: a positron emission tomographic study with magnetic resonance imaging comparison.
Kamson DO; Mittal S; Buth A; Muzik O; Kupsky WJ; Robinette NL; Barger GR; Juhász C
Mol Imaging; 2013; 12(5):327-37. PubMed ID: 23759373
[TBL] [Abstract][Full Text] [Related]
6. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
7. Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod.
Lukas RV; Juhász C; Wainwright DA; James CD; Kennedy E; Stupp R; Lesniak MS
J Neurooncol; 2019 Jan; 141(1):111-120. PubMed ID: 30415456
[TBL] [Abstract][Full Text] [Related]
8. Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors.
Juhász C; Muzik O; Chugani DC; Chugani HT; Sood S; Chakraborty PK; Barger GR; Mittal S
J Neurooncol; 2011 May; 102(3):409-15. PubMed ID: 20676727
[TBL] [Abstract][Full Text] [Related]
9. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
[TBL] [Abstract][Full Text] [Related]
10. In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors.
Juhász C; Chugani DC; Muzik O; Wu D; Sloan AE; Barger G; Watson C; Shah AK; Sood S; Ergun EL; Mangner TJ; Chakraborty PK; Kupsky WJ; Chugani HT
J Cereb Blood Flow Metab; 2006 Mar; 26(3):345-57. PubMed ID: 16079785
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma.
Guastella AR; Michelhaugh SK; Klinger NV; Kupsky WJ; Polin LA; Muzik O; Juhász C; Mittal S
Mol Imaging; 2016; 15():. PubMed ID: 27151136
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Dynamic O-(2-[
Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
[TBL] [Abstract][Full Text] [Related]
13. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma.
Bosnyák E; Michelhaugh SK; Klinger NV; Kamson DO; Barger GR; Mittal S; Juhász C
Clin Nucl Med; 2017 May; 42(5):341-347. PubMed ID: 28195901
[TBL] [Abstract][Full Text] [Related]
15. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
[TBL] [Abstract][Full Text] [Related]
16. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients.
Christensen M; Kamson DO; Snyder M; Kim H; Robinette NL; Mittal S; Juhász C
J Radiat Oncol; 2014 Jun; 3(2):131-138. PubMed ID: 25414765
[TBL] [Abstract][Full Text] [Related]
18. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
19. FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.
Lohmann P; Stavrinou P; Lipke K; Bauer EK; Ceccon G; Werner JM; Neumaier B; Fink GR; Shah NJ; Langen KJ; Galldiks N
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):591-602. PubMed ID: 30327856
[TBL] [Abstract][Full Text] [Related]
20. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
